PTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells

Journal of Cellular Biochemistry

Volumn 94, Issue 1, 2005, Pages 117-125

  Okamura, Hirohiko ^a   Yoshida, Kaya ^a   Morimoto, Hiroyuki ^a   Haneji, Tatsuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Akt; Apoptosis; Calyculin A; EGR 1; PTEN

Indexed keywords

CALYCULIN A; DOUBLE STRANDED RNA; EARLY GROWTH RESPONSE FACTOR 1; OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE B; DNA BINDING PROTEIN; EGR1 PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; OXAZOLE DERIVATIVE; PHOSPHATASE; PRIMER DNA; PTEN PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN CONDENSATION; CONTROLLED STUDY; EARLY RESPONSE GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; DOWN REGULATION; DRUG EFFECT; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; DNA-BINDING PROTEINS; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; HUMANS; IMMEDIATE-EARLY PROTEINS; OXAZOLES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 17644370362     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20283     Document Type: Article

References (41)

1. Arends MJ, Wyllie AH. 1991. Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 32:223-254.
2. Cao X, Mahendran R, Guy GR, Tan YH. 1992. Protein phosphatase inhibitors induce the sustained expression of the Egr-1 gene and the hyperphosphorylation of its gene product. J Biol Chem 267:12991-12997.
3. Cao X, Mahendran R, Guy GR, Tan YH. 1993. Detection and characterization of cellular EGR-1 binding to its recognition site. J Biol Chem 268:16949-16957.
4. Chandar N, Billig B, McMaster J, Novak J. 1992. Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer 65:208-214.
5. Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W. 2002. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21:5289-5300.
6. Cohen P, Holmes CFB, Tsukitani Y. 1990. Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem Sci 15:98-102.
7. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. 2000. Serine/threonine protein kinases and apoptosis. Exp Cell Res 256:34-41.
8. Davies MA, Koul D, Dhesi H, Herman R, McDonnell TJ, McConkey D, Yung WKA, Steck PA. 1999. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59:2551-2556.
9. Farrow B, Evers BM. 2003. Activation of PPARγ increases PTEN expression in pancreatic cancer cells. Biochem Biophys Res Commun 301:50-53.
10. Fujita M, Seta C, Fukuda J, Kobayashi S, Haneji T. 1999. Induction of apoptosis in human oral squamous carcinoma cell lines by protein phosphatase inhibitors. Oral Oncol 35:401-408.
11. Fujita M, Goto K, Yoshida K, Okamura H, Morimoto H, Kito S, Fukuda J, Haneji T. 2004. Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells. Oral Oncol 40:199-206.
12. Goto K, Fukuda J, Haneji T. 2002. Okadaic acid stimulates apoptosis through expression of Fas receptor and Fas ligand in human squamous cell carcinoma cells. Oral Oncol 38:16-22.
13. Huang RP, Fan Y, deBelle I, Ni Z, Matheny W, Adamson ED. 1998. Egr-1 inhibits apoptosis during the UV response: Correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ 5:96-106.
14. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, Hartshorne DJ. 1989. Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159:871-877.
15. Kito S, Shimizu K, Okamura H, Yoshida K, Fujita M, Morimoto H, Morimoto Y, Ohba T, Haneji T. 2003. Cleavage of nucleolin and argyrophilic nucleolar organizer region associated proteins in apoptosis-induced cells. Biochem Biophys Res Commun 300:950-956.
16. Kyrylenko S, Roschier M, Korhonen P, Salminen A. 1999. Regulation of PTEN expression in neuronal apoptosis. Mol Brain Res 73:198-202.
17. Lemaire P, Revelant O, Bravo R, Charnay P. 1988. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85:4691-4695.
18. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275:1943-1947.
19. Liu C, Rangnekar VM, Adamson E, Mercola D. 1998. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5:3-28.
20. Maehama T, Dixon JE. 1999. PTEN: A tumour suppressor that functions as phospholipid phosphatase. Trends Cell Biol 9:125-128.
21. Milbrandt J. 1987. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797-799.
22. Morimoto Y, Ohba T, Kobayashi S, Haneji T. 1997. The protein phosphatase inhibitors okadaic acid and calyculin A induce apoptosis in human osteoblastic cells. Exp Cell Res 230:181-186.
23. Morimoto H, Morimoto Y, Ohba T, Kido H, Kobayashi S, Haneji T. 1999a. Inhibitors of protein synthesis and RNA synthesis protect against okadaic acid-induced apoptosis in human osteosarcoma cell line MG63 cells but not in Saos-2 cells. J Bone Miner Metab 17:266-273.
24. Morimoto Y, Morimoto H, Kobayashi S, Ohba T, Haneji T. 1999b. The protein phosphatase inhibitors, okadaic acid and calyculin A, induce apoptosis in human submandibular gland ductal cell line HSG cells. Oral Dis 5:104-110.
25. Morimoto Y, Kito S, Ohba T, Morimoto H, Okamura H, Haneji T. 2001. Alteration of argyrophilic nucleolar organizer region associated (Ag-NOR) proteins in apoptosis-induced human salivary gland cells and human squamous carcinoma cells. J Oral Pathol Med 30:193-199.
26. Morimoto H, Okamura H, Yoshida K, Kitamura S, Haneji T. 2004. Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2α pathway in human osteoblastic MG63 cells. J Biochem (in press).
27. N'cho M, Brahmi Z. 1999. Fas-mediated apoptosis in T cells involves the dephosphorylation of the retinoblastoma protein by type 1 protein phosphatase. Hum Immunol 60:1183-1194.
28. Okamura H, Morimoto H, Haneji T. 2001. Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity. Oral Oncol 37:379-385.
29. Okamura H, Morimoto H, Fujita M, Nasu F, Sasaki E, Haneji T. 2002. Suppression of Egr-1 expression in human oral squamous carcinoma cells by okadaic acid. Oral Oncol 38:779-784.
30. Okamura H, Yoshida K, Morimoto H, Sasaki E, Haneji T. 2004. Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells. Int J Oncol (in press).
31. Paramio JM, Navarro M, Segrelles C, Gomez-Casero E, Jorcano JL. 1999. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene 18:7462-7468.
32. Stambolic V, Suzuki A, delaPompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39.
33. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW. 2001. Regulation of PTEN transcription by p53. Mol Cell 8:317-325.
34. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
35. Steller H. 1995. Mechanisms and genes of cellular suicide. Science 267:1445-1449.
36. Sukhatme VP, Cao X, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T, LeBeau MM, Adamson ED. 1988. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37-43.
37. Thiel G, Cibelli G. 2002. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287-292.
38. Tsugawa K, Jones MK, Sugimachi K, Sarfeh IJ, Tarnawski AS. 2002. Biological role of phosphatase PTEN in cancer and tissue injury healing. Front Biosci 7:e245-e251.
39. Urade M, Ogura T, Mima T, Matsuya T. 1992. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer 69:2589-2597.
40. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, deBelle I. 2001. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 3:1124-1128.
41. Yoshida K, Okamura H, Morimoto H, Nagata T, Haneji T. 2003. Stimulation of receptor activator of nuclear factor-kappa B ligand (RANKL) in mouse osteoblastic cells by okadaic acid. Biomed Res 14:126-132.